Cipla | CIPLA - Loan Capital

Stock Price
1,306.50
Daily Change
-10.70 -0.81%
Monthly
6.72%
Yearly
-15.24%
Q2 Forecast
1,266.51

Cipla reported INR2.98B in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
aTyr Pharma USD 12.51M 12.11M Dec/2025
Bio Path USD 0 0 Mar/2025
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cara Therapeutics USD 0 0 Mar/2025
Cipla INR 2.98B 454.6M Sep/2025
Dr.Reddys Laboratories INR 11.61B 29M Dec/2025
Esperion Therapeutics USD 457.65M 9.5M Dec/2025
Immunic USD 0 0 Jun/2024
Infinity Pharmaceuticals USD 0 0 Jun/2022
Minerva Neurosciences USD 0 86.58M Sep/2024
Nektar Therapeutics USD 63.16M 44.35M Dec/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sun Pharmaceuticals INR 3.62B 36.4M Sep/2025
TherapeuticsMD USD 0 0 Mar/2022
UPL INR 182.37B 10.19B Sep/2025